MiRXES (Singapore Subsidiary) is VC-Funded and has raised funding across Series D and Series C rounds. It is backed by Mirxes Holding and Ark Bio.
Alternatives.pe tracks MiRXES (Singapore Subsidiary)'s funding history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-07-21
Browse all uploaded documents here
Extracted Financial Statement 2024
Extracted Financial Statement
ViewAudited Financial Statement 2022
Audited Financial Statement
ViewAudited Financial Statement 2021
Audited Financial Statement
ViewAudited Financial Statement 2020
Audited Financial Statement
ViewExplore the latest updates and insights
Mirxes raises $50M in series D round.
MiRXES Invests $5M in Altara Ventures Fund, Contributing to $130.6M Total
Investment into Altara Ventures
MiRxes Raises $77M in Series C Round.
All Shares Transitioned to Mirxes Holding Company
A view of the number of employees over time
Key members of the management team